LPL Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,660
Closed -$226K 3234
2019
Q4
$226K Buy
+3,660
New +$195K ﹤0.01% 3004
2017
Q4
Sell
-3,550
Closed -$217K 3028
2017
Q3
$217K Sell
3,550
-455
-11% -$25.9K ﹤0.01% 2606
2017
Q2
$214K Sell
4,005
-295
-7% -$14.4K ﹤0.01% 2535
2017
Q1
$204K Sell
4,300
-6,358
-60% -$296K ﹤0.01% 2477
2016
Q4
$441K Sell
10,658
-1,931
-15% -$82.5K ﹤0.01% 1841
2016
Q3
$605K Sell
12,589
-1,631
-11% -$77.5K 0.01% 1554
2016
Q2
$590K Sell
14,220
-18,990
-57% -$819K 0.01% 1533
2016
Q1
$1.45M Sell
33,210
-4,520
-12% -$200K ﹤0.01% 1393
2015
Q4
$2.51M Buy
37,730
+19,182
+103% +$1.28M 0.01% 1030
2015
Q3
$1.16M Buy
18,548
+657
+4% +$56K 0.01% 1150
2015
Q2
$1.64M Sell
17,891
-2,221
-11% -$191K 0.01% 1025
2015
Q1
$1.56M Buy
20,112
+1,090
+6% +$80.8K 0.01% 1052
2014
Q4
$1.19M Buy
19,022
+2,874
+18% +$169K 0.01% 1188
2014
Q3
$814K Sell
16,148
-5,826
-27% -$282K ﹤0.01% 1412
2014
Q2
$1.02M Sell
21,974
-18,230
-45% -$720K 0.01% 1305
2014
Q1
$1.6M Buy
40,204
+7,524
+23% +$342K 0.01% 953
2013
Q4
$1.23M Sell
32,680
-26,508
-45% -$886K 0.01% 1107
2013
Q3
$1.8M Buy
59,188
+22,320
+61% +$646K 0.01% 844
2013
Q2
$836K Buy
+36,868
New +$842K 0.01% 1230

Other funds holding BIB

LPL Financial's BIB Position: Q1 2020 in Review

LPL Financial sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2020, closing a stake of 3,660 shares — an estimated $226K sold.

LPL Financial first reported a position in BIB in Q2 2013 and held it in 19 quarters. The position peaked at $2.51M in Q4 2015. 26 funds tracked by Wall St. Rank hold BIB as of Q1 2020.

  • LPL Financial reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
  • LPL Financial sold 3,660 ProShares Ultra NASDAQ Biotechnology shares in Q1 2020, an estimated $226K.
  • LPL Financial first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and held it in 19 quarters.
  • LPL Financial's ProShares Ultra NASDAQ Biotechnology position peaked at $2.51M in Q4 2015.
  • 26 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2020.

Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.